Factors Determining the Selection of Organic Reactions by Medicinal Chemists and the Use of These Reactions in Arrays (Small Focused Libraries)
Top Cited Papers
- 21 September 2010
- journal article
- review article
- Published by Wiley in Angewandte Chemie-International Edition
- Vol. 49 (44), 8082-8091
- https://doi.org/10.1002/anie.201002238
Abstract
Synthetic organic reactions are a fundamental enabler of small‐molecule drug discovery, and the vast majority of medicinal chemists are initially trained—either at universities or within industry—as synthetic organic chemists. The sheer breadth of synthetic methodology available to the medicinal chemist represents an almost endless source of innovation. But what reactions do medicinal chemists use in drug discovery? And what criteria do they use in selecting synthetic methodology? Why are arrays (small focused libraries) so powerful in the lead‐optimization process? In this Minireview, we suggest some answers to these questions and also describe how we have tried to expand the number of robust reactions available to the medicinal chemist.Keywords
This publication has 27 references indexed in Scilit:
- How to improve R&D productivity: the pharmaceutical industry's grand challengeNature Reviews Drug Discovery, 2010
- The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?Drug Discovery Today, 2009
- Defining optimum lipophilicity and molecular weight ranges for drug candidates—Molecular weight dependent lower logD limits based on permeabilityBioorganic & Medicinal Chemistry Letters, 2009
- Physiochemical drug properties associated with in vivo toxicological outcomesBioorganic & Medicinal Chemistry Letters, 2008
- Generation of a Set of Simple, Interpretable ADMET Rules of ThumbJournal of Medicinal Chemistry, 2008
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidatesNature Reviews Drug Discovery, 2007
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Drug research: myths, hype and realityNature Reviews Drug Discovery, 2003
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997